Article
High IDH1 expression is associated with a poor prognosis in cytogenetically normal acute myeloid leukemia.
International journal of cancer - 1 Sept 2015
Ma Qiu-Ling, Wang Jing-Han, Wang Yun-Gui, Hu Chao, Mu Qi-Tian, Yu Meng-Xia, Wang Lei, Wang Dong-Mei, Yang Min, Yin Xiu-Feng, Chen Fei-Fei, Lu Sha-Sha, Chen Jian, Zhu Zhi-Juan, Chen Sai-Juan, Jin Jie
Abstract excerpt
The prognostic value of IDH1 mutations has been systematically evaluated in acute myeloid leukemia (AML) patients recently. However, the role of IDH1 expression in AML is still under exploration. To investigate the clinical significance, we analyzed the IDH1/2 expression in 320 patients with cytogenetically normal AML (CN-AML) by quantitative real-time reverse-transcription polymerase chain reaction. High...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
